Search research articles
Contact Us
Filters
Showing results (71-80 of 140) with videos related to
Page
of 14
Sort By:
Seminars in Thrombosis and Hemostasis
|
May 10, 2021
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature
Joshua W Branstetter, Amy L Kiskaddon, Madeleine A King, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 15, 2023
Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis
Hilary Whitworth, Ernest K Amankwah, Marisol Betensky, et al.
Seizure
|
June 9, 2020
Effects of the ketogenic diet on platelet counts and global coagulation tests in childhood epilepsy
Anastasia Dressler, Häfele Chiara, Franz Benninger, et al.
European Journal of Pediatrics
|
August 5, 2025
European thromboprophylaxis practice amongst paediatric cardiology units
Ciara Ryan, Michal Odermarsky, Daniel De Wolf, et al.
Thrombosis Research
|
March 22, 2025
A survey on clinical practice in monitoring and management of bleeding in children with haemophilia A on emicizumab prophylaxis in the PedNet centres
Susanna Ranta, Ester Zapotocka, Nadine G Andersson, et al.
Haematologica
|
August 28, 2025
Benchmarking prophylaxis with factor concentrates: reference data on annualized bleeding rates in children with severe hemophilia
Susanna Ranta, Marloes De Kovel, Martin Olivieri, et al.
Thrombosis and Haemostasis
|
September 2, 2016
Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial
Gili Kenet, Hervé Chambost, Christoph Male, et al.
American Heart Journal
|
September 8, 2019
A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study
R Mark Payne, Kristin M Burns, Andrew C Glatz, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
March 27, 2024
Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B
Richard Lemons, Michael Wang, Julie Curtin, et al.
The Lancet. Haematology
|
April 13, 2025
Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial
Christoph Male, Anthonie W A Lensing, Anthony K C Chan, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 140) with videos related to
Sort By:
Page
of 14
Seminars in Thrombosis and Hemostasis
|
May 10, 2021
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature
Joshua W Branstetter, Amy L Kiskaddon, Madeleine A King, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 15, 2023
Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis
Hilary Whitworth, Ernest K Amankwah, Marisol Betensky, et al.
Seizure
|
June 9, 2020
Effects of the ketogenic diet on platelet counts and global coagulation tests in childhood epilepsy
Anastasia Dressler, Häfele Chiara, Franz Benninger, et al.
European Journal of Pediatrics
|
August 5, 2025
European thromboprophylaxis practice amongst paediatric cardiology units
Ciara Ryan, Michal Odermarsky, Daniel De Wolf, et al.
Thrombosis Research
|
March 22, 2025
A survey on clinical practice in monitoring and management of bleeding in children with haemophilia A on emicizumab prophylaxis in the PedNet centres
Susanna Ranta, Ester Zapotocka, Nadine G Andersson, et al.
Haematologica
|
August 28, 2025
Benchmarking prophylaxis with factor concentrates: reference data on annualized bleeding rates in children with severe hemophilia
Susanna Ranta, Marloes De Kovel, Martin Olivieri, et al.
Thrombosis and Haemostasis
|
September 2, 2016
Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial
Gili Kenet, Hervé Chambost, Christoph Male, et al.
American Heart Journal
|
September 8, 2019
A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study
R Mark Payne, Kristin M Burns, Andrew C Glatz, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
March 27, 2024
Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B
Richard Lemons, Michael Wang, Julie Curtin, et al.
The Lancet. Haematology
|
April 13, 2025
Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial
Christoph Male, Anthonie W A Lensing, Anthony K C Chan, et al.
Page
of 14